Tag: CYTR

Blue Horseshoe Stocks: Weekly Wrap-up, Fresh Ideas

Evoke Pharma, Inc. EVOK

Leading into yesterday’s session, some people might have looked at a gapped-down, backsliding, new 52-week low play like EVOK, and dismissed it out of hand. Those people would have missed out on the prime opportunity we provided our readers in tagging the stock for observation in yesterday’s premarket report.

Whenever we see a stock showing any indication of bounce activity off of an annual low, it puts us on high alert, and plays like EVOK are the reason for that. The stock traded in a range from 2.51 up to 3.28, a solid single-session swing amounting to 31% and it appears as if the massive gap on the chart beginning at 3.50 is already in the process of being filled, with the stock trading as high as 3.70 in early trading this morning.

We want to see the premarket low of 3.15 hold as support on any pullbacks in order to sustain our immediate interest in EVOK.

______

Added Notes:
Tokai Pharmaceuticals. Inc. TKAI and CytRx Corp. CYTR – These plays are currently boasting charts that are incredibly similar to the situation we found EVOK in yesterday, with major gap-downs leading to new lows, with a hint of bounce activity in yesterday’s session. We’re going to place these stocks on alert this morning as well.

Tempur Sealy International, Inc. TPX – Options Idea

Yesterday, as we caught TPX coming off of an earnings beat, we wanted to put a range of call contracts on watch to leverage the expected subsequent activity to our advantage. Due to the fact that there were no weekly calls to track, we submitted a longer-term set of contracts, yet the gain opportunities were immediate.

Our target calls, the TPX 08/19 $70-80 Calls, all made appreciable moves on the day:

$70 Calls – Range: 3.00-5.40 – Max Gain: 80%
$75 Calls – Range:  .90-1.96 – Max Gain: 118%
$80 Calls – Range: .25-.40 – Max Gain: 60%

We’ll continue to monitr these plays in the week ahead leading into their expiration.

____

Fresh Idea:
Expert traders may want to take a look at AMZN Weekly $762.50-770 Calls for potential daytrades today on the heels of yesterday’s post-market earnings beat.

North Springs Resources Corp. NSRS

NSRS was also an item of interest from yesterday’s report, having been entered into the extended watchlist as a potential bottom-bouncer. We got just the type of rebound we were after, as the stock traded up from a low of .033 to a high of .043. That was good for a nice 30% gain opportunity, and the stock will remain on our radar provided it can continue to build a higher base level of support off of its bottom.

Extended Watchlist:
DNRG, SING, VHUB, SPHS, SPU, MCRB(Watching for Bottom)

Blue Horseshoe Stocks: SITO News & More

SITO Mobile Ltd.  SITO

Popping up on our scanner this morning is SITO, which, per a premarket PR (excerpt below) released this morning, has entered into an asset purchase agreement with Hipcricket (HIPP).

Upon approval, this deal will create in SITO, one of the largest mobile ad/marketing firms in the industry. This also comes in the wake of what has apparently been a good year for the company. According to SITO’s CEO, 2014 was “a transformative year… which included 27% year-over-year revenue growth”.

These are all reasons why the fact that we’re catching SITO coming off of its 52-low could carry some potentially exciting opportunities on the chart. We’ll have our eyes peeled for further updates on the progress of the deal as we tag SITO for monitoring in the days and weeks ahead.

JERSEY CITY, N.J., Jan. 21, 2015 (GLOBE NEWSWIRE) — SITO Mobile Ltd. (SITO), a leading mobile engagement platform provider, announced today that it has entered into an asset purchase agreement (“Agreement”) with Hipcricket Inc. (HIPP), the leader in mobile engagement and analytics, for $4.5 million in cash, to acquire substantially all of its assets. Hipcricket reported revenues of $26.7 million for the fiscal year ended February 28, 2014 and currently holds 21 U.S. patents covering technology inventions. >> FULL PR

Medican Enterprises, Inc. MDCN

Speaking of plays coming up off of their annual lows, MDCN represented a feat of perfect timing for us yesterday. We noted that the stock had reached its lowest point of the past year on Thursday, and the rebound offered up the chance at a 57% intraday move to kick off yesterday’s trading session.

Beginning from an early low of .023, the stock surged as high as .036 around 11am, with the bulk of the day’s volume (which exceeded the monthly average by threefold) having traded in that time frame.

Congrats go out to any of our readers who were able to reap a profit off of that excellently-timed call of MDCN!

We’re interested to follow the main MDCN storyline, being the recently announced purchase of a 7200sq.ft. commercial facility and dispensary in Phoenix, AZ. We’ll be certain to relay any developments as they come down the pipe.


Netflix, Inc. NFLX – Options Ideas

NFLX continues to surge on yesterday’s after-hours earnings beat in this morning’s premarket activity, and it sets us up nicely for a possible play on some options calls.

What we’d expect to see is some early profit-taking, causing a classic dip-and-rip, and thereafter we’ll be looking to take advantage. Provided the stock holds support above today’s premarket low of 394.80 we’ll be paying close attention to the  $395-410 Calls for possible intraday/intraweek flip opportunities.

Side Note: GPRO is also bouncing off a recent bottom, and has our attention as a solid recovery play, therefore we will want to radar call options there as well.

Extended Watchlist:
SCOK, ANV, CYTR, AUY, IAG, AMLH

Blue Horseshoe Stocks: MDCN Refocus & More

Pervasip Corp. PVSP

To kick off this short week we’d like to take note of PVSP, a super-subpenny stock that has recently awoken from the dead and begun to show some vigorous swings on the chart. PVSP has been bouncing around in a rough channel between .0002 and .0004 for the past couple of weeks.

Every so often we like to watch super-subpennies like this one for the low-risk-high-reward factor; with little room to fall, the rock bottom prices represent a true ground-floor opportunity. Many times in the past have we caught on with a play in this situation and reaped the benefit of rapid and monstrous upswings. We’ll keep a close eye on PVSP for the possible chance to do it again.

Last week the company announced that it had completed deal that will allow it to write approximately $2M off of its existing debt for an up-front sum of just $100K, and a later payment of $25K in October. >>> VIEW PR 

Medican Enterprises, Inc. MDCN

MDCN is a marijuana-related stock that we’ve had on our long term radar for quite some time. Toward the beginning of the year we re-tagged the stock for monitoring and today seems like a good time to focus in more intently on a couple of key points that seem to indicate a possible opportunity ahead.

In addition to a recent property acquisition with potentially exciting implications (PR excerpt below), we’re catching MDCN off of its 52-week low which was just realized on Thursday. Our regular readers are well aware of how fond we are of stocks coming up off of their annual lows. We’ve successfully navigated countless plays in this exact situation, and in many cases have come up with major gains for our efforts.

LAS VEGAS–(BUSINESS WIRE)–Medican Enterprises Inc. (MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announced that it has entered into a purchase agreement to acquire a 7,200 square foot retail and commercial property in Phoenix, Arizona.

The property is currently leased through August 2018 to an Arizona state licensed medical marijuana dispensary. Per the purchase agreement, the lease agreement will be assigned to Medican. >> FULL PR

Extended Watchlist:
CYTR, ISR, AUY, EHTH, SWHC, FRO, IBIO